Malignant Uveal Neoplasm — Trials

Malignant Uveal Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

232 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 59
Recruiting: 29
Ph III recruiting: 6
Growth YoY: —
Industry share: 36%
Top sponsor: IDEAYA Biosciences
Termination share: 33.3%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (34)

clinicaltrialsPublishedShowing 1–2 of 2 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00036816	Vaccine Therapy in Treating Patients With Melanoma of the Eye	terminated	Phase 3	13	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	2	Sep 24, 2012	clinicaltrials
NCT00110123	Intravenous or Hepatic Arterial Infusion of Fotemustine in Treating Patients With Unresectable Liver Metastases From Eye Melanoma	terminated	Phase 3	171	European Organisation for Research and Treatment of Cancer - EORTCNETWORK	4